In a pre-clinical model of non-small cell lung cancer (NSCLC),the concomitant inhibition of TGF-β1 and integrin β3 silencing, resulted in decreased lymph node metastasis. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.